R. Pacifici et al., QUANTIFICATION OF THE VARIATION DUE TO LYSING TECHNIQUE IN IMMUNOPHENOTYPING OF HEALTHY AND HIV-INFECTED INDIVIDUALS, Clinical biochemistry, 31(3), 1998, pp. 165-172
Objective: We performed a side-by-side comparison between three stain-
then-lyse commercially available methods (Ortho-mune Lysing solution,
FACS lysing solution and ImmunoPrep reagent system) and a lyse-then-st
ain method using hypotonic NH4Cl. The major difference between these m
ethods is that only in the latter the aliquots of sample to be distrib
uted into diverse tubes for the various antibody combinations were obt
ained from a lysis step performed in the same tube. Design and Methods
: Lymphocytes from 20 healthy and 20 HIV+ subjects were phenotyped by
dual color flow cytometry using a standard procedure that included the
establishing of a lymphocyte gate on light scatter bit map and the us
e of the minimal acceptable antibody combinations, i.e., CD45/CD14, CD
3/CD4 and CD3/CD8, according to CDC recommendations. All samples were
processed in triplicate to assess tube-to-tube variability. Results: I
n healthy subjects, erythrocytes pre-lysing provided the highest purit
y and recovery in the lymphocyte gate, and allowed the best identifica
tion of CD4(+) lymphocytes. Most remarkably, erythrocytes pre-lysing s
ignificantly outdid all other methods in reducing tube-to-tube variabi
lity. This allowed the attainment of highest correlation between CD3() cells identified by CD3/CD4 and CD3/CD8 antibody combinations and th
e minimum variability between the sum of the %CD3(+)CD4(+) and %CD3(+)
CD8(+), and the total %CD3(+). This higher reliability of the pre-lysi
s method was particularly evident with HIV+ patients in which the lymp
hocyte gate was often and unpredictably contaminated by debris and oth
er cell types. Conclusions: The present study demonstrates that lysing
erythrocytes in a single tube and distributing aliquots of lysed bloo
d into different tubes for the various antibody combinations provides
superior results for routine immunophenotyping. Copyright (C) 1998 The
Canadian Society of Clinical Chemists.